SCANIS, Inc, is in the business of providing value based CAD (computer aided detection) technologies for image-based medical screening techniques. SCANIS, Incorporated has developed patented advanced image analysis software and systems that have been shown to detect pre-cancerous tissue and cancerous tissue in mammograms. SCANIS' first product is the MAMMEX MammoCAD System. This product represents a significant breakthrough in CAD (computer aided detection) and incorporates the collective knowledge of leading medical imaging physicians. The MAMMEX MammoCAD system automatically scans, evaluates, and identifies mammographic features associated with tumor masses and microcalcifications not always seen by radiologists. In a study of 12,860 patients, CAD was shown to increase the detection of breast cancer by over 20%.